Market Tracker

05/26 5:16pm ET

Achillion Pharmaceuticals Inc (NASDAQ:ACHN)

4.21
Delayed Data
As of May 26
 +0.06 / +1.45%
Today’s Change
3.15
Today|||52-Week Range
10.06
+1.94%
Year-to-Date
No recent news for Achillion Pharmaceuticals Inc.

Today’s Trading

Previous close4.15
Today’s open4.13
Day’s range4.13 - 4.32
Volume1,382,402
Average volume (3 months)1,374,163
Market cap$567.4M
Dividend yield--
Data as of 3:59pm ET, 05/26/2017

Growth & Valuation

Earnings growth (last year)-1,025.00%
Earnings growth (this year)-52.00%
Earnings growth (next 5 years)+5.23%
Revenue growth (last year)-77.31%
P/E ratioNM
Price/Sales37.63
Price/Book1.42

Competitors

 Today’s
change
Today’s
% change
ENTAEnanta Pharmaceutica...-0.23-0.76%
BYSIBeyondspring Inc-0.13-0.39%
VSARVersartis Inc-0.32-2.05%
PRTKParatek Pharmaceutic...-0.65-3.13%
Data as of 4:00pm ET, 05/26/2017

Financials

Next reporting dateAugust 9, 2017
EPS forecast (this quarter)-$0.16
Annual revenue (last year)$15.0M
Annual profit (last year)-$61.7M
Net profit margin-411.37%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Milind S. Deshpande
CFO, Principal Accounting Officer &
Executive VP
Mary Kay Fenton
Corporate headquarters
New Haven, Connecticut

Forecasts